BioCryst Pharmaceuticals

2190 Parkway Lake Drive
Birmingham, Alabama 35244

Phone (205) 444-4600
Fax (205) 444-4640
info@biocryst.com

Print Print page     Email Email page

Investor Relations

Stock Price Information
Last Trade: Jul 2, 2009 at
 4:03 PM ET  
Price:   $ 4.10
Change:    $0.06

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.

Recent Releases

May 14, 2009
BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology

May 8, 2009
BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

May 7, 2009
BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009

View all releases »



BioCryst Pharmaceuticals Inc.,   BCRX (NASDAQ) (founded 1986)
Offering Date Shares & Price
Initial Public Offering March 1994 2.3 million shares @ $6.50
Secondary Public Offering September 1996 2.3 million shares @ $10.00
Follow-on Public Offering November 1999 2.0 million shares @ $25.25
Follow-on Public Offering February 2004 3.6 million shares @ $6.00
Follow-on Public Offering February 2005 4.3 million shares @ $5.50
Follow-on Public Offering December 2005 2.2 million shares @ $13.46
Follow-on Public Offering August 2007 8.3 million shares @ $7.80